Warts from immunosuppressed organ transplant recipients (OTR) persist over years and may progress into non-melanoma skin cancer. Human papillomaviruses (HPV) are considered the causal agents for the development of such warts. We isolated the novel type HPV-117 from a persisting wart by rolling circle amplification. One hundred eighteen warts from immunocompetent patients (IC) and 49 warts from OTR were analyzed by HPV-117 E6 type-specific PCR. As inferred from a phylogenetic analysis, the new type HPV-117 belonged to alpha-PV species 2, including the most similar types HPV-10 and HPV-94. The general prevalence of HPV-117 in warts was 2% in IC (2/118), and 12% in OTR (6/49). The high viral load in dysplastic cells of a Verruca vulgaris was shown by in situ hybridization. Our results suggest an active role of the novel type in the development of cutaneous warts of OTR.
Introduction
The complete genome of more than 100 human papillomavirus (HPV) types has been characterized. HPV are classified into mucosotropic (alpha-PV), cutaneotropic (beta-PV and gamma-PV) and cutaneous, wart-associated types (species 2 and 4 of alpha-PV, mu-PV and nu-PV) based on sequence similarities and clinical manifestations (de Villiers et al., 2004) . Most HPV types have been initially isolated and identified from genital/mucosal lesions, and PCR based methods have identified a huge number of L1 gene fragments of putatively novel cutaneous HPV types (Forslund et al., 1999 (Forslund et al., , 2003 . By convention, a new PV type requires the isolation and characterization of the entire genome (de Villiers et al., 2004) , and viral genomic fragments are not sufficient to identify novel PV types.
In the general population, cutaneous warts are induced by alpha-PV species 2 and species 4 (HPV-2, -27 and -57) as well as by mu-PV (HPV-1 and -63) and nu-PV (HPV-41). HPV-2, -27 and -57 are the most prevalent types with this respect (Rübben et al., 1993 (Rübben et al., , 1997 . From a phylogenetic perspective, cutaneotropic alpha-PV species 2 and species 4 may derive from the otherwise mucosotropic alpha-PV (Muñoz et al., 2003) .
A large number of organ transplant recipients (OTR) develop warts and wart-like lesions during immunosuppression. Presence of cutaneous warts increase with time after transplantation, and 39% of 560 OTR have developed Verrucae vulgares after 7 years (Bouwes Bavinck et al., 2007) . Cutaneous warts of OTR persist over years, are often atypical and can show dysplasia. Moreover, they are associated and co-localize with non-melanoma skin cancer, indicating that benign warts may progress into malignant skin cancer during immunosuppression (Blessing et al., 1989; Euvrard et al., 2003) .
A more diverse range of cutaneotropic HPV types has been reported in warts of OTR compared to immunocompetent patients (IC) (Shamanin et al., 1994; Obalek et al., 1992; Harwood et al., 1999) . However, a subpopulation of warts from OTR does not appear infected with known HPV types, although they show all characteristics of HPVinduced skin alterations (Köhler et al., 2009 ). Here, we report the complete genome of a novel, wart-associated HPV type isolated from a persisting wart of an OTR, who has been previously considered HPV negative. We examine the histological localization of the novel type by in situ hybridization and the prevalence in warts of IC (n = 118) and of OTR (n = 49) using type-specific PCR.
Results and discussion
The novel type had the principle genome organization found in the majority of mucosotropic alpha-PV types, consisting of the four large genes E1, E2, L2 and L1 and the three smaller genes E6, E7 and E5 (García-Vallvé et al., 2005) . The complete genome of HPV-117 comprised 7895 bp, and the L1 nt sequence showed the highest similarity of 87.5% with both HPV-10 and HPV-94, as inferred from a The alignment for the multi-gene phylogenetic analysis was 2421 aa positions in length, and 1553 of these sites (64%) were parsimonyinformative (55.5 per terminal taxon). Fig. 1 shows the best-scoring ML-tree (−ln = 67264.44), with the statistical support values for the two phylogenetic approaches used. alpha-PV were monophyletic, irrespectively whether the data were analyzed under the likelihood criterion (bootstrap support value from ML analysis: 100 LBS) or the Bayesian approach (Bayesian posterior probability: 1.00 BPP). Lowrisk human alpha-PV types were a paraphyletic assemblage, from which PV clades with other character traits derived. Such clades included non-human PV that were polyphyletic, as well as high-risk human alpha-PV types. Cutaneous wart-associated alpha-PV types constituted two monophyletic groups (alpha-PV species 2 and 4) that were only distantly related to each other. The new type HPV-117 belonged to alpha-PV species 2 (100 LBS, 1.00 BPP), but the closest relative could not be determined unequivocally (either HPV-10 or HPV-94). The results support the principle correspondence between phylogenetic relationships and viral properties within mucosotropic alpha-PV (Muñoz et al., 2003) .
The ability of PV to induce proliferation of the infected cells has been attributed mainly to the two viral oncogenes E6 and E7. The corresponding oncoproteins bind host cellular proteins, with the tumor suppressors, p53 and retinoblastoma protein (pRb), as major targets (Münger et al., 2004) . The E7 ORF of the vast majority of PV contains the conserved pRb-binding core sequence LxCxE (Boulet et al., 2007) . However, this motif is absent from a subset of alpha-PV species 2 including HPV-117 (Figs 1 and 2). The lack of a pRbbinding motif is rare among PV and is only known from ruminant delta-PV and epsilon-PV as well as from a few solitary other types. Moreover, this character trait may correlate with specific pathologies (Narechania et al., 2004) .
A number of zinc-binding domains is characteristic for the two oncogenes E6 and E7 (Nomine et al., 2006; Liu et al., 2006) . The E7 ORF of HPV-117 exhibited one regular zinc-binding domain at aa position 50 [CxxC(x) 29 CxxC] (Fig. 2) . However, the E6 ORF contained only one of two regular zinc-binding domains [CxxC(x) 29 CxxC] (data not shown). The first started at aa position 29 and was separated by 36 aa from the mutated second motif. The loss of the second zinc-finger domain at nt position 417 was due to a missense mutation (A instead of G), resulting in a replacement of tyrosin for cystein at aa position 105 (C105Y). This mutation was also found in sequences amplified from 8 warts that were infected with HPV-117 using type-specific primers. Thus, the loss of the second zinc-finger domain is not due to experimental artefacts, but is biologically present in the novel type HPV-117.
As a component of alpha-PV species 2, HPV-117 had a putative E5 ORF (nt 4152-4295) between the genes E2 and L2, as it has been also described for the closely related type HPV-94 (de Villiers and Gunst, 2009). In alpha-PV, four types of E5 proteins have been identified, with different biochemical properties and corresponding to phylogenetic groups (Bravo and Alonso, 2004) . The E5beta-protein is present in alpha-PV species 2, 3, 4, 14 and 15 including HPV-117 and has a distinct hydrophobic profile over its aa sequence.
Overall, little is known about the causal HPV types in warts of immunosuppressed OTR due to the small number of studies analyzing the presence of HPV in warts of this cohort. Cutaneous (beta-, and gamma-PV) and wart-associated HPV types (species A2 and A4 of alpha-PV, mu-, and nu-PV) were found in 76% (37/49) of OTR by PCR based methods. HPV-117 was detected in warts from 2% (2/118) of the general population and from 12% (6/49) of OTR. Of these HPV-117 positive warts, multiple infections with additional cutaneous HPV types were found in both lesions of IC and in 4/6 of OTR, while single infections were present in 2/6 warts of OTR. Moreover, the novel type was present in the nucleus of dysplastic keratinocytes of the wart shown by in situ hybridization (Fig. 3) . The high viral load, and the presence in the lesion, suggests that HPV-117 is the etiological agent of this cutaneous wart.
In conclusion, HPV-117 belongs to alpha-PV species 2, whose types induce cutaneous warts and share viral properties. The new type is localized in dysplastic keratinocytes and is a widely distributed type among OTR. To further determine the pathogenicity of the novel type, functional analyses of viral genes in human cells and human primary keratinocytes, and their interactions with UV-radiation, are required. Our study may contribute to a better understanding how benign warts may progress into malignant skin cancer during immunosuppression.
Materials and methods

Patients
The Verruca vulgaris from an immunosuppressed renal transplant recipient (42-year-old male) persisted over 24 months. The wart was removed from the back of the right hand by deep curettage to the dermis at the time of surgery. The biopsy was divided into two halves, one was snap frozen in liquid nitrogen and stored at −80°C, and the other half of the biopsy was fixed in formalin and embedded in paraffin. Paraffin embedded sections of the Verruca vulgaris were used for histological evaluation and in situ hybridization. Moreover, we examined 167 paraffin embedded warts (confirmed by histology), including 118 IC and 49 immunosuppressed OTR. This study was approved by the local ethics committee at the Charité, University Hospital, Berlin, Germany (number Si. 248) and was conducted according to the Declaration of Helsinki.
HPV detection and isolation of new types
DNA was isolated from tissue using QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). HPV detection of cutaneous types (beta-, and gamma-PV) and wart-associated types (species A2 and A4 of alpha-PV, mu-, and nu-PV) was performed by PCR based methods as previously described (Köhler et al., 2009) . To obtain novel HPV type(s), rolling circle amplification (RCA) of the episomal viral DNA was performed with a TempliPhi 500 Amplification kit (Amersham Biosciences, Munich, Germany). We followed an optimized protocol using additional nucleotides to obtain higher folds of amplification as previously described (Schulz et al., 2009) . Purified DNA of the complete HPV genome was cloned into pUC19 (Invitrogen, Karlsruhe, Germany) at the BamHI restriction site, and sequencing was performed by primer walking (GENterprise, Mainz, Germany). The clone, and the corresponding complete genome sequence, was submitted to the International Reference Centre for Papillomaviruses at the German Cancer Research Centre, Heidelberg, Germany. The novel type was designated HPV-117 (GenBank accession no. GQ246950).
Protein prediction and phylogenetic analyses
Open reading frames (ORF) were predicted using 'ORFinder' (http://www.ncbi.nlm.nih.gov/gorf/gorf.html). They were confirmed by the manual alignment of nucleotide (nt) and amino acid (aa) sequences to homologous regions of most similar PV types in 'BioEdit' (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Primary sequence analysis of the predicted proteins was performed with 'ProtParam' (www.expasy.ch/tools/protparam.html), 'Prosite' (Hulo et al., 2008) and 'PSORT II' ( http://psort.ims.u-tokyo.ac.jp/ form.html).
The taxon sample for phylogenetic analyses covered the currently known diversity of wart-associated PV types, embedded in a representative set of alpha-PV, and comprised 28 complete PV sequences (including HPV-117 and 4 outgroup taxa; see Supplementary Table S1 ). After exclusion of the highly divergent E4 gene region, an aa alignment (comprising the genes E1-E2-L2-L1) was constituted using 'MAFFT' (v6.523; (Katoh et al., 2005) ; http://align.bmr.kyushuu.ac.jp/mafft/software/). The final matrix is available at http://htcc. pt-dlr.de/dateien/KoehlerAlpha.nex. A sequence identity matrix of a L1 gene nt alignment also constituted in 'MAFFT' was generated by 'BioEdit' (v7.0.0; (Hall, 1999) . Phylogenetic analyses were conducted using 'RAxML' (Stamatakis, 2006; Stamatakis et al., 2008) ; http:// www.phylo.org/portal/Home.do) and 'MrBayes' v3.1.2 (Huelsenbeck and Ronquist, 2001) , applying the rtREV substitution model (Dimmic et al., 2002) as previously described (Gottschling et al., 2007) . Bayesian calculations were carried out by using the resources of the Computational Biology Service Unit from Cornell University, which is partially funded by Microsoft Corporation. We ran two independent analyses of 4 (1 cold and 3 heated) mcmc chains with 6,000,000 cycles, sampled every 1000th cycle, with an appropriate burn-in (10%).
In situ hybridization
In situ hybridization of paraffin-embedded tissue sections (5 μm) was performed as previously described (Nafz et al., 2007) . Briefly, the tissue was digested with proteinase K and pre-hybridized. Hybridization was conducted with pre-hybridization buffer, supplemented with 500 ng biotinylated HPV genome DNA (HPV-117 or HPV-8, both cloned in pUC19) using a biotin-nick translation kit (Roche, Mannheim, Germany). After the washing steps, slides were incubated with a streptavidin-horseradish peroxidase (HRP) conjugate, and the signal was amplified with the biotin derivative and amplification reagent biotinyltyramid (Perkin Elmer, Norwalk, CT). Red precipitate of 3-amino-9-ethylcarbazol chromogen substrate (AEC; Dako, Hamburg, Germany) activated by HRP represent HPV DNA, and nuclei were counterstained with hematoxylin.
Type-specific PCR
To determine the prevalence of the novel type, we analyzed cutaneous warts of IC and OTR. HPV-117 E6 type-specific PCR was performed with forward and reverse primers (5′-GCCTCAAACATTGG-GAACAT-3′ and 5′-CAGTCGTCGTCGTTCGTTAC-3′). Each amplification mix contained in a final volume of 50 μl 0.5 μmol L − 1 of each gene-specific primer, 0.2 mmol L − 1 dNTPs, 1.5 mmol L − 1 MgCl 2 in 1× PCR buffer (Qiagen), 0.3 units of Taq polymerase (Qiagen) and 1 μL of template DNA. The corresponding PCR was performed under the following conditions: initial denaturation at 94°C for 4 min; 40 cycles comprising the steps 94°C for 45 s, 60°C for 45 s, 72°C for 45 s, and final elongation at 72°C for 4 min. The PCR products with a size of 152 bp were separated by electrophoresis in 2% agarose gel, and the isolated products were sequenced. The sequences were aligned using the software program CodonCode Aligner (version 3.0, CodonCode Corporation, Dedham, USA) and were compared to the prototype sequence of HPV-117. 
